Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research

Clinical trial NCT07085559 · RECRUITING

Trial details

NCT number: NCT07085559
Sponsor: Anhui Provincial Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma (MM)Plasma Cell Leukemia (PCL)AL Amyloidosis (AL)

Start date: 2025-06-23
Primary completion: 2027-06-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.